Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A0A3Q8IC46
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0016409 | palmitoyltransferase activity | 5 | 8 |
GO:0016417 | S-acyltransferase activity | 5 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016746 | acyltransferase activity | 3 | 8 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 8 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 8 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 8 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.316 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.281 |
CLV_NRD_NRD_1 | 249 | 251 | PF00675 | 0.302 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.333 |
CLV_PCSK_FUR_1 | 188 | 192 | PF00082 | 0.316 |
CLV_PCSK_FUR_1 | 259 | 263 | PF00082 | 0.426 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.278 |
CLV_PCSK_KEX2_1 | 249 | 251 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.390 |
CLV_PCSK_PC7_1 | 255 | 261 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.273 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.545 |
CLV_PCSK_SKI1_1 | 255 | 259 | PF00082 | 0.302 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 270 | 274 | PF00082 | 0.337 |
DEG_APCC_DBOX_1 | 190 | 198 | PF00400 | 0.516 |
DOC_CYCLIN_yClb1_LxF_4 | 93 | 99 | PF00134 | 0.392 |
DOC_CYCLIN_yCln2_LP_2 | 18 | 24 | PF00134 | 0.374 |
DOC_MAPK_gen_1 | 260 | 271 | PF00069 | 0.599 |
DOC_MAPK_MEF2A_6 | 110 | 118 | PF00069 | 0.424 |
DOC_MAPK_MEF2A_6 | 262 | 271 | PF00069 | 0.630 |
DOC_MAPK_NFAT4_5 | 270 | 278 | PF00069 | 0.609 |
DOC_PP1_RVXF_1 | 268 | 275 | PF00149 | 0.613 |
DOC_PP2B_LxvP_1 | 18 | 21 | PF13499 | 0.374 |
DOC_PP4_FxxP_1 | 143 | 146 | PF00568 | 0.448 |
DOC_USP7_MATH_1 | 7 | 11 | PF00917 | 0.438 |
LIG_14-3-3_CanoR_1 | 249 | 258 | PF00244 | 0.505 |
LIG_Actin_WH2_2 | 233 | 251 | PF00022 | 0.414 |
LIG_Actin_WH2_2 | 95 | 112 | PF00022 | 0.379 |
LIG_BRCT_BRCA1_1 | 139 | 143 | PF00533 | 0.414 |
LIG_FHA_1 | 236 | 242 | PF00498 | 0.353 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.445 |
LIG_FHA_2 | 251 | 257 | PF00498 | 0.545 |
LIG_LIR_Apic_2 | 140 | 146 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 124 | 135 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 205 | 209 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 9 | 14 | PF02991 | 0.286 |
LIG_NRBOX | 203 | 209 | PF00104 | 0.374 |
LIG_NRBOX | 236 | 242 | PF00104 | 0.398 |
LIG_Pex14_1 | 11 | 15 | PF04695 | 0.314 |
LIG_Pex14_1 | 274 | 278 | PF04695 | 0.696 |
LIG_Pex14_2 | 31 | 35 | PF04695 | 0.500 |
LIG_PTB_Apo_2 | 200 | 207 | PF02174 | 0.314 |
LIG_PTB_Apo_2 | 25 | 32 | PF02174 | 0.374 |
LIG_PTB_Apo_2 | 91 | 98 | PF02174 | 0.361 |
LIG_PTB_Phospho_1 | 200 | 206 | PF10480 | 0.374 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 138 | 142 | PF00017 | 0.374 |
LIG_SH2_STAP1 | 15 | 19 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.192 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.545 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.320 |
LIG_SUMO_SIM_par_1 | 63 | 68 | PF11976 | 0.313 |
LIG_TRAF2_1 | 3 | 6 | PF00917 | 0.421 |
LIG_TYR_ITIM | 125 | 130 | PF00017 | 0.414 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.700 |
MOD_CK2_1 | 250 | 256 | PF00069 | 0.516 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.407 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.375 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.543 |
MOD_N-GLC_1 | 202 | 207 | PF02516 | 0.374 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.405 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.635 |
MOD_PIKK_1 | 40 | 46 | PF00454 | 0.616 |
MOD_Plk_1 | 202 | 208 | PF00069 | 0.374 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.447 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.401 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.374 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.341 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.334 |
TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.487 |
TRG_ER_diArg_1 | 248 | 250 | PF00400 | 0.516 |
TRG_ER_diArg_1 | 258 | 261 | PF00400 | 0.584 |
TRG_ER_diArg_1 | 53 | 56 | PF00400 | 0.614 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HSZ8 | Leptomonas seymouri | 61% | 99% |
A0A1X0NW18 | Trypanosomatidae | 36% | 100% |
A4HDT8 | Leishmania braziliensis | 85% | 100% |
E9AH93 | Leishmania infantum | 100% | 100% |
E9AX73 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QAA3 | Leishmania major | 92% | 100% |